The US FDA is not expecting a decrease in ANDA receipts in fiscal years 2019 and 2020, even though its budget request suggests that a drop will happen.
The agency wrote in its FY 2020 budget request congressional justification that after receiving 1,044 ANDAs in FY 2018,...